146 related articles for article (PubMed ID: 24632442)
1. Mutation and low pH effect on the stability as well as unfolding kinetics of transthyretin dimer.
Xue Q; Zheng QC; Zhang JL; Cui YL; Chu WT; Zhang HX
Biophys Chem; 2014 May; 189():8-15. PubMed ID: 24632442
[TBL] [Abstract][Full Text] [Related]
2. Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.
Rodrigues JR; Simões CJ; Silva CG; Brito RM
Protein Sci; 2010 Feb; 19(2):202-19. PubMed ID: 19937650
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
Azevedo EP; Pereira HM; Garratt RC; Kelly JW; Foguel D; Palhano FL
Biochemistry; 2011 Dec; 50(51):11070-83. PubMed ID: 22091638
[TBL] [Abstract][Full Text] [Related]
4. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
Lai Z; Colón W; Kelly JW
Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
[TBL] [Abstract][Full Text] [Related]
5. Quaternary structure, aggregation and cytotoxicity of transthyretin.
Mizuguchi M; Yokoyama T; Nabeshima Y; Kawano K; Tanaka I; Niimura N
Amyloid; 2012 Jun; 19 Suppl 1():5-7. PubMed ID: 22439750
[TBL] [Abstract][Full Text] [Related]
6. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.
Palaninathan SK; Mohamedmohaideen NN; Snee WC; Kelly JW; Sacchettini JC
J Mol Biol; 2008 Oct; 382(5):1157-67. PubMed ID: 18662699
[TBL] [Abstract][Full Text] [Related]
7. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.
Lashuel HA; Wurth C; Woo L; Kelly JW
Biochemistry; 1999 Oct; 38(41):13560-73. PubMed ID: 10521263
[TBL] [Abstract][Full Text] [Related]
8. Why is Leu55-->Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers.
Yang M; Lei M; Huo S
Protein Sci; 2003 Jun; 12(6):1222-31. PubMed ID: 12761393
[TBL] [Abstract][Full Text] [Related]
9. The sequence-dependent unfolding pathway plays a critical role in the amyloidogenicity of transthyretin.
Yang M; Yordanov B; Levy Y; Brüschweiler R; Huo S
Biochemistry; 2006 Oct; 45(39):11992-2002. PubMed ID: 17002298
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen-bond network and pH sensitivity in transthyretin: Neutron crystal structure of human transthyretin.
Yokoyama T; Mizuguchi M; Nabeshima Y; Kusaka K; Yamada T; Hosoya T; Ohhara T; Kurihara K; Tomoyori K; Tanaka I; Niimura N
J Struct Biol; 2012 Feb; 177(2):283-90. PubMed ID: 22248451
[TBL] [Abstract][Full Text] [Related]
11. Initial conformational changes of human transthyretin under partially denaturing conditions.
Yang M; Lei M; Bruschweiler R; Huo S
Biophys J; 2005 Jul; 89(1):433-43. PubMed ID: 15821170
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic versus mutation dependent instability/flexibility: a comparative analysis of the structure and dynamics of wild-type transthyretin and its pathogenic variants.
Lei M; Yang M; Huo S
J Struct Biol; 2004 Nov; 148(2):153-68. PubMed ID: 15477096
[TBL] [Abstract][Full Text] [Related]
13. The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells.
Zhang F; Hu C; Dong Y; Lin MS; Liu J; Jiang X; Ge Y; Guo Y
Arch Biochem Biophys; 2013 Jul; 535(2):120-7. PubMed ID: 23523753
[TBL] [Abstract][Full Text] [Related]
14. Different disease-causing mutations in transthyretin trigger the same conformational conversion.
Steward RE; Armen RS; Daggett V
Protein Eng Des Sel; 2008 Mar; 21(3):187-95. PubMed ID: 18276611
[TBL] [Abstract][Full Text] [Related]
15. Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.
Pasquato N; Berni R; Folli C; Alfieri B; Cendron L; Zanotti G
J Mol Biol; 2007 Feb; 366(3):711-9. PubMed ID: 17196219
[TBL] [Abstract][Full Text] [Related]
16. Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.
Hurshman Babbes AR; Powers ET; Kelly JW
Biochemistry; 2008 Jul; 47(26):6969-84. PubMed ID: 18537267
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils.
Castro-Rodrigues AF; Gales L; Saraiva MJ; Damas AM
Acta Crystallogr D Biol Crystallogr; 2011 Dec; 67(Pt 12):1035-44. PubMed ID: 22120741
[TBL] [Abstract][Full Text] [Related]
18. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
Sörgjerd K; Ghafouri B; Jonsson BH; Kelly JW; Blond SY; Hammarström P
J Mol Biol; 2006 Feb; 356(2):469-82. PubMed ID: 16376939
[TBL] [Abstract][Full Text] [Related]
19. Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation.
Esperante SA; Varejāo N; Pinheiro F; Sant'Anna R; Luque-Ortega JR; Alfonso C; Sora V; Papaleo E; Rivas G; Reverter D; Ventura S
J Biol Chem; 2021 Sep; 297(3):101039. PubMed ID: 34343569
[TBL] [Abstract][Full Text] [Related]
20. Fluorotryptophan Incorporation Modulates the Structure and Stability of Transthyretin in a Site-Specific Manner.
Sun X; Dyson HJ; Wright PE
Biochemistry; 2017 Oct; 56(41):5570-5581. PubMed ID: 28920433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
